ExploreWatchlistsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Marketable securities, non-current

JCR Pharmaceuticals Co.,Ltd. (4552)

Market cap
¥79.9B
P/E ratio
47x
JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 20259,629+5.58%
Mar 31, 20249,120+2.85%
Mar 31, 20238,867+297.62%
Mar 31, 20222,230-13.30%
Mar 31, 20212,572+6.81%
Mar 31, 20202,408-18.12%
Mar 31, 20192,941-7.92%
Mar 31, 20183,194-10.97%
Mar 31, 20173,588-15.54%
Mar 31, 20164,248+9.16%
Mar 31, 20153,891

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat